Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Principal U.S. Small Cap Index ETF | PSC | Dec 24, 2024 | 52.04 | +0.93 |
Priority Income Fund | PRIF-L | Dec 24, 2024 | 23.37 | -1.68 |
Priority Income Fund | PRIF-K | Dec 24, 2024 | 21.51 | +1.42 |
Priority Income Fund D Pref | PRIF-D | Dec 24, 2024 | 24.15 | -1.43 |
Priority Income Fund F Pref | PRIF-F | Dec 24, 2024 | 24.24 | -1.78 |
Priority Income Fund G Pref | PRIF-G | Dec 24, 2024 | 25.34 | 0.00 |
Priority Income Fund I Pref | PRIF-I | Dec 24, 2024 | 23.17 | -0.61 |
Priority Income Fund J Pref | PRIF-J | Dec 24, 2024 | 22.85 | -0.35 |
Priority Income Fund Pref | PRIF-H | Dec 24, 2024 | 24.04 | -0.87 |
Priority Technology | PRTH | Dec 24, 2024 | 10.83 | +17.46 |
Privia Health Group | PRVA | Dec 24, 2024 | 19.90 | -0.05 |
Pro-Dex | PDEX | Dec 24, 2024 | 48.13 | +4.86 |
ProAssurance | PRA | Dec 24, 2024 | 16.07 | +1.32 |
Procaps Group | PROC | Dec 24, 2024 | 2.48 | -6.06 |
Procept BioRobotics | PRCT | Dec 24, 2024 | 83.72 | +3.17 |
Processa Pharmaceuticals | PCSA | Dec 24, 2024 | 0.87 | +4.04 |
Procore Technologies | PCOR | Dec 24, 2024 | 77.79 | +1.63 |
Procter & Gamble | PG | Dec 24, 2024 | 168.94 | +0.49 |
Professional Diversity Network | IPDN | Dec 24, 2024 | 0.41 | -0.44 |
Proficient Auto Logistics | PAL | Dec 24, 2024 | 7.84 | +2.08 |
Profire Energy | PFIE | Dec 24, 2024 | 2.54 | +0.79 |
Profound Medical | PROF | Dec 24, 2024 | 6.98 | -0.29 |
ProFrac A | ACDC | Dec 24, 2024 | 7.35 | +2.37 |
PROG | PRG | Dec 24, 2024 | 42.51 | +1.87 |
Progress Software | PRGS | Dec 24, 2024 | 66.26 | +1.49 |
Progressive | PGR | Dec 24, 2024 | 243.24 | +0.93 |
Progyny | PGNY | Dec 24, 2024 | 14.53 | +0.28 |
ProKidney | PROK | Dec 24, 2024 | 1.78 | +5.33 |
Prologis | PLD | Dec 24, 2024 | 104.70 | +0.54 |
ProMIS Neurosciences | PMN | Dec 24, 2024 | 0.91 | -1.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.